Psychometric attributes of the Hospital Anxiety and Depression Scale in Parkinson's disease

Movement Disorders

Volumn 24, Issue 4, 2009, Pages 519-525

  Rodriguez Blazquez, Carmen ^a   Frades Payo, Belen ^a   Forjaz, Maria João ^b   de Pedro Cuesta, Jesus ^a   Martinez Martin, Pablo ^a   Aguilar, M ^c   Quilez Ferrer, P ^c   Alvarez Sauco M ^d   Bayes A ^e   Blazquez M ^f   Bergareche, A ^g   Campos, V ^h   Carballo, M ⁱ   Catalan M J ^j   Chacon J ^k   Cubo, E ^l   Fernandez Garcia J M ^m   Garcia Ruiz Espiga P ^j   Kulisevsky, J ⁿ   Linazasoro, G ^o   Lopez del Val J ^p   Martinez Castrillo J C ^q   Mendoza, A ^r   Mir, P ⁱ   Posada, I ^s   Vallderiola, F ^t   Vela, L ^u   Vivancos, F ^v   Ybot, I ^v   more..

^a CARLOS III INSTITUTE OF HEALTH   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL MÚTUA DE TERRASSA   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^e CENTRO MÉDICO TEKNON   (Spain)

^f HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^g Hospital Bidasoa   (Spain)

^h University Teaching Hospital   (Spain)

ⁱ HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^j HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^k HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^l Burgos Hospital   (Spain)

^m HOSPITAL DE BASURTO   (Spain)

ⁿ HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^o Gipuzkoa Polyclinic   (Spain)

^p Lozano Blesa Hospital   (Spain)

^q HOSPITAL RAMÓN Y CAJAL   (Spain)

^r HOSPITAL GENERAL DE SEGOVIA   (Spain)

^s HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^t CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^u HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^v HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

more..

Author keywords

Anxiety; Depression; Parkinson's disease; Psychometric properties; Rating scales

Indexed keywords

ACCURACY; ADULT; AGED; ANXIETY DISORDER; ARTICLE; CLINICAL ASSESSMENT; CONSTRUCT VALIDITY; CRONBACH ALPHA COEFFICIENT; CROSS-SECTIONAL STUDY; DEPRESSION; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; RATING SCALE; SCORING SYSTEM; ANXIETY; CLINICAL TRIAL; HEALTH STATUS; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; NONPARAMETRIC TEST; OBSERVATION; ONSET AGE; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; REPRODUCIBILITY;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ANXIETY; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; OBSERVATION; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 67651171516     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22321     Document Type: Article

References (46)

1. Mondolo F, Jahanshahi M, Grana A, Biasutti E, Cacciatori E, Di Benedetto P. Evaluation of anxiety in Parkinson's disease with some commonly used rating scales. Neurol Sci 2007;28:270-275.
2. Leentjens AF. Depression in Parkinson's disease: conceptual issues and clinical challenges. J Geriatr Psychiatry Neurol 2004; 17:120-126.
3. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370.
4. Marinus J, Leentjens AF, Visser M, Stiggelbout AM, van Hilten JJ. Evaluation of the hospital anxiety and depression scale in patients with Parkinson's disease. Clin Neuropharmacol 2002; 25:318-324.
5. Schrag A, Barone P, Brown RG, et al. Depression rating scales in Parkinson's disease: critique and recommendations. Mov Disord 2007;22:1077-1092.
6. McDowell I. Measuring health. A guide to rating scales and questionnaires. Third Edition:294-302. New York: Oxford University Press, 2006.
7. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002;52:69-77.
8. Mondolo F, Jahanshahi M, Grana A, Biasutti E, Cacciatori E, Di Benedetto P. The validity of the hospital anxiety and depression scale and the geriatric depression scale in Parkinson's disease. Behav Neurol 2006;17:109-115.
9. Grupo ELEP. A longitudinal study of patients with Parkinson's disease (ELEP): aims and methodology. Rev Neurol 2006;42: 360-365.
10. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752.
11. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967;17:427-442.
12. Marinus J, Visser M, Stiggelbout AM, et al. A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA. J Neurol Neurosurg Psychiatry 2004; 75:388-395.
13. Martinez-Martin P, Benito-Leon J, Burguera JA, et al. The SCOPA-Motor Scale for assessment of Parkinson's disease is a consistent and valid measure. J Clin Epidemiol 2005;58:674-679.
14. Marinus J, Visser M, Verwey NA, et al. Assessment of cognition in Parkinson's disease. Neurology 2003;61:1222-1228.
15. Friedberg G, Zoldan J, Weizman A, Melamed E. Parkinson Psychosis Rating Scale: a practical instrument for grading psychosis in Parkinson's disease. Clin Neuropharmacol 1998;21:280-284.
16. Martinez-Martín P, Forjaz MJ, Cubo E, Frades B, de Pedro Cuesta J, and the ELEP Project Members. Global versus factor-related impression of severity in Parkinson's disease: a new Clinimetric Index (CISI-PD). Mov Disord 2006;21:208-214.
17. Miller MD, Paradis CF, Houck PR, et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 1992;41:237-248.
18. Visser M, Marinus J, Sitggelbout AM, van Hilten JJ. Assessment of Autonomic Dysfunction in Parkinson's disease: the SCOPA-AUT. Mov Disord 2004;19:1306-1312.
19. Marinus J, Visser M, van Hilten JJ, Lammers GJ, Stiggelbout AM. Assessment of sleep and sleepiness in Parkinson disease. Sleep 2003;26:1049-1054.
20. Martinez-Martin P, Cubo-Delgado E, Aguilar-Barbera M, et al. A pilot study on a specific measure for sleep disorders in Parkinson's disease: SCOPA-Sleep. Rev Neurol 2006;43:577-583.
21. Marinus J, Visser M, Martínez-Martín P, van Hilten JJ, Stiggelbout AM. A short psychosocial questionnaire for patients with Parkinson's disease: the SCOPA-PS. J Clin Epidemiol 2003;56: 61-67.
22. EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
23. Visser M, Marinus J, van Hilten JJ, Schipper RG, Stiggelbout AM. Assessing comorbidity in patients with Parkinson's disease. Mov Disord 2004;19:824-828.
24. Badia X, Herdman M, Kind P. The influence of ill-health experience on the valuation of health. Pharmacoeconomics 1998;13: 687-696.
25. McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 1995;4:293-307.
26. Holmes W, Bix B, Shea J. SF-20 score and item distributions in a human immunodeficiency virus-seropositive sample. Med Care 1996;34:562-569.
27. Eisen M, Ware JE, Jr, Donald CA, Brook RH. Measuring components of children's health status. Med Care 1979;17:902-921.
28. Jenkinson C, Fitzpatrick R, Norquist J, Findley L, Hughes K. Crosscultural evaluation of the Parkinson's Disease Questionnaire: tests of data quality, score reliability, response rate, and scaling assumptions in the United States, Canada, Japan, Italy, and Spain J Clin Epidemiol 2003;56:843-847.
29. Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002;11:193-205.
30. Fitzpatrick R, Davey C, Buxton MJ, Jones DR. Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess 1998;2:1-74.
31. Swinscow TDV, Campbell MJ. Correlation and regression. Statistics at Square One, 9th ed. BMJ Publishing Group; 1997.
32. Wyrwich KW, Wolinsky FD. Identifying meaningful intra-individual change standards for health-related quality of life measures. J Eval Clin Pract 2000;6:39-49.
33. Sloan JA, Cella D, Hays RD, RAND. Clinical significance of patient-reported questionnaire data: another step toward consensus. J Clin Epidemiol 2005;58:1217-1219.
34. Flint AJ, Rifat SL. Factor structure of the hospital anxiety and depression scale in older patients with major depression. Int J Geriatr Psychiatry 2002;17:117-123.
35. Quintana JM, Padierna A, Esteban C, Arostegui I, Bilbao A, Ruiz I. Evaluation of the psychometric characteristics of the Spanish version of the Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 2003;107:216-221.
36. Martinez-Martin P, Serrano-Duenas M, Forjaz MJ, Serrano MS. Two questionnaires for Parkinson's disease: are the PDQ-39 and PDQL equivalent? Qual Life Res 2007;16:1221-1230.
37. Calne SM, Lidstone SC, Kumar A. Psychosocial issues in young-onset Parkinson's disease: current research and challenges. Parkinsonism Relat Disord 2008;14:143-150.
38. Schrag A, Hovris A, Morley D, Quinn N, Jahanshahi M. Young-versus older-onset Parkinson's disease: impact of disease and psychosocial consequences. Mov Disord 2003;18:1250-1256.
39. Baba Y, Putzke JD, Whaley NR, Wszolek ZK, Uitti RJ. Gender and the Parkinson's disease phenotype. J Neurol 2005;252:1201-1205.
40. Ehrt U, Brønnick K, De Deyn PP, et al. Subthreshold depression in patients with Parkinson's disease and dementia - clinical and demographic correlates. Int J Geriatr Psychiatry 2007;22:980-985.
41. Horn S. Some psychological factors in Parkinsonism. J Neurol Neurosurg Psychiatry 1974;37:27-31.
42. Terwee CB, Dekker FW, Wiersinga WM, Prummel MF, Bossuyt PM. On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation. Qual Life Res 2003;12:349-362.
43. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003;41:582-592.
44. Wyrwich KW, Bullinger M, Aaronson N, Hays RD, Patrick DL, Symonds T. Estimating clinically significant differences in quality of life outcomes. Qual Life Res 2005;14:285-295.
45. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:407-415.
46. de Vet HC, Terwee CB, Ostelo RW, Beckerman H, Knol DL, Bouter LM. Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change. Health Qual Life Outcomes 2006;4:54.